Coronary stents and anaesthesia;Endoprothèses coronaires et anesthésie

Annales Francaises d'Anesthesie et de Reanimation

Volumn 26, Issue 9, 2007, Pages 784-790

  Lehot, J J ^a,b   Staat, P ^a   Ffrench, P ^a   Vichova, Z ^a,b   Cannesson, M ^a,b  

^a LOUIS PRADEL HOSPITAL   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Anaesthesia; Antiplatelet; Aspirin; Clopidogrel; Coronary; Coronary artery disease; Stent; Surgery; Ticlopidin

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PYRIDINE DERIVATIVE; SALICYLIC ACID; THIENOPYRIDINE; TICLOPIDINE; UNCLASSIFIED DRUG;

ANESTHESIA; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; SHORT SURVEY; THROMBOSIS;

ANESTHESIA; COMBINED MODALITY THERAPY; CORONARY STENOSIS; DRUG DELIVERY SYSTEMS; FIBRINOLYTIC AGENTS; HUMANS; STENTS;

EID: 34548354786     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2007.07.070     Document Type: Short Survey

References (42)

1. Sabate S., Canet J., Munoz S., Castillo J., Lucas M., and Mayoral V. Epidemiology of anesthesia in Catalunia, Spain, in 2003. Med. Clin. (Barc.) 126 Suppl 2 (2006) 13-18
2. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon expandable stent implantation stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med. 331 (1994) 489-495
3. Hannan E.L., Racz M.J., Walford G., Jones R.H., Ryan T.J., Bennett E., et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N. Engl. J. Med. 352 (2005) 2174-2183
4. Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
5. Kotani J., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J. Am. Coll. Cardiol. 47 (2006) 2108-2111
6. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
7. Ong A.T., Hoye A., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Sonnenschein K., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J. Am. Coll. Cardiol. 45 (2005) 947-953
8. Lamartine S. Suivi du traitement antiagrégant plaquettaire après implantation d'une endoprothèse coronaire pharmacoactive. Thèse, Lyon, 29 septembre 2006.
9. Katritsis D.G., Karvouni E., and Ioannidis J.P. Meta-analysis comparing drug-eluting stents with bare metal stents. Am. J. Cardiol. 95 (2005) 640-643
10. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabaté M., et al. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J. Am. Coll. Cardiol. 45 (2005) 954-959
11. Congrès de l'American College of Cardiology, Atlanta, mars 2006.
12. Alfonso F., Suarez A., Angiolillo D.L., Sabate M., Escaned J., Moreno R., et al. Findings of intravascular ultrasound during acute stent thrombosis. Heart 90 (2004) 1455-1459
13. Nebeker J.R., Virmani R., Bennett C.L., Hoffman J.M., Samore M.H., Alvarez J., et al. Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) Project. J. Am. Coll. Cardiol. 47 (2006) 175-181
14. Lev E.I., Patel R.T., Maresh K.J., Guthikonda S., Granada J., De Lao T., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J. Am. Coll. Cardiol. 47 (2006) 27-33
15. Glowczynska R., Malek L.A., Spiewak M., Filipiak K.J., Grabowski M., Kisiel B., et al. Clinical, biochemical and genetical resistance to clopidogrel in a patient with the recurrent coronary stent thrombosis-a case report and review of the literature. Intern. J. Cardiol. 111 (2006) 326-328
16. Patrono C., Coller B., FitzGerald G.A., Hirsh J., and Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 126 (2004) 234S-264S
17. Cuisset T., Frere C., Quilici J., Barbou F., Morange P.E., Hovasse T., et al. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J. Thromb. Haemost. 4 (2006) 542-549
18. Nguyen T.A., Diodati J.G., and Pharand C. Resistance to clopidogrel: a review of the evidence. J. Am. Coll. Cardiol. 45 (2005) 1157-1164
19. Michelson A.D., Cattaneo M., Eikelboom J.W., Gurbel P., Kottke-Marchant K., Kunicki T.J., et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J. Thromb. Haemost. 3 (2005) 1309-1311
20. Rocca B., and Patrono C. Determinants of the interindividual variability in response to antiplatelet drugs. J. Thromb. Haemost. 3 (2005) 1597-1602
21. Ferrari E., Benhamou M., Cerboni P., and Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J. Am. Coll. Cardiol. 45 (2005) 456-459
22. Conférence d'experts 2001. http://www.sfar.org/pdf/aapconfexp.pdf 30 juillet 2006.
23. Kaluza G.L., Joseph J., Lee J.R., Raizner M.E., and Raizner A.E. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J. Am. Coll. Cardiol. 35 (2000) 1288-1294
24. Wilson S.H., Fasseas P., Orford J.L., Lennon R.J., Horlocker T., Charnoff N.E., et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. JACC Cardiol. 42 (2003) 234-240
25. Brichon P.Y., Boitet P., Dujon A., Mouroux J., Peillon C., Riquet M., et al. Perioperative in-stent thrombosis after lung resection performed within 3 months of coronary stenting. Eur. J. Cardiothorac. Surg. 30 (2006) 793-796 (Epub 2006 Sep 22)
26. Fléron M.H., Dupuis M., Mottet P., Le Feuvre C., and Godet G. Chirurgie générale et endoprothèse coronaire : pensez au sirolimus !. Ann. Fr. Anesth. Reanim. 22 (2003) 733-735
27. Murphy J.T. Thrombosis of sirolimus-eluting coronary stent in the postanesthesia care unit. Anesth. Analg. 101 (2005) 971-973
28. Decoene C., Vincentelli A., Fabre O., Crepin F., and Pol A. Thrombose tardive d'une endoprothèse coronaire pharmacoactive après arrêt des agents antiplaquettaires. Ann. Fr. Anesth. Reanim. 24 (2005) 1275-1277
29. Cuthill J.A., Young S., Greer I.A., and Oldroyd K. Anaesthetic considerations in a parturient with critical coronary artery disease and a drug-eluting stent presenting for caesarean section. Int. J. Obs. Anesth. 14 (2005) 167-171
30. Compton P.A., Zankar A.A., Adesanya A.O., Banerjee S., and Brilakis E.S. Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am. J. Cardiol. 1 (2006) 1212-1213 (Epub 2006 Sep 7)
31. Vicenzi M.N., Meislitzer T., Heitzinger B., Halaj M., Fleisher L.A., and Metzler H. Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br. J. Anaesth. 96 (2006) 686-693
32. Landesberg G., Shatz V., Akopnik I., Wolf Y.G., Mayer M., Berlatzky Y., et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J. Am. Coll. Cardiol. 42 (2003) 1547-1554
33. Samama C.M., Thiry D., Elalamy I., Diaby M., Guillosson J.J., Kieffer E., et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology 94 (2001) 74-78
34. Lehot J.J., Piriou V., Durand de Gevigney G., and Coriat P. Le patient à risque de thrombose de stent coronaire en période périopératoire : une situation de plus en plus fréquente. Ann. Fr. Anesth. Reanim. 24 (2005) 1247-1249
35. Albaladejo P., Marret E., Piriou V., and Samama C.M. Le groupe d'experts de la Société française d'anesthésie et de réanimation (Sfar). Gestion du traitement antiplaquettaire oral chez les patients porteurs d'endoprothèses coronaires. Ann. Fr. Anesth. Reanim. 25 (2006) 796-798
36. Barner H.B. Status of percutaneous coronary intervention and coronary artery bypass. Eur. J. Cardiothorac. Surg. 30 (2006) 419-424
37. Grines C.L., Bonow R.O., Casey D.E., Gardner T.J., Lockhart P.B., Molinerto D.J., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
38. Price M.J., Coleman J.L., Steinhubl S.R., Wong G.B., Cannon C.P., and Teirstein P.S. Onset and offset of platelet inhibition after high-dose clopidogrel loading and standard daily therapy measured by a point-of-care assay in healthy volunteers. Am. J. Cardiol. 98 (2006) 681-684
39. Mantz J., and Samama C.M. Essai STRATAGEM : la mobilisation de tous est indispensable !. Ann. Fr. Anesth. Reanim. 25 (2006) 133-134 [Éditorial]
40. http://www.sfed.org/pdf/Prisecharg_sousanticoagplaq.pdf.
41. o 2.
42. Coriat P., and Amour J. Mécanisme et prévention des complications coronariennes de la chirurgie non cardiaque. In: Sfar (Ed). Les essentiels. Congrès national d'anesthésie et de réanimation (2006), Elsevier, Paris 253-263